COVID-19 update: running a life science business - supporting staff and managing operations

Supporting staff and managing operations during the COVID-19 pandemic

Join us this Thursday for another webinar from the BIA, updating on the issues surrounding running a UK life science business in the current climate and with a particular focus on supporting your staff and managing operations.

This week Steve Bates and Michael Warren will be joined by two guest speakers:

  • Gareth Jones, Director of People and Change at KPMG, to talk about supporting staff and planning for the longer term implications.
  • Priya Mande, COO of PsiOxus Therapeutics, to discuss some of the challenges on the front line.
Speaker bios
Steve Bates

Chief Executive Officer

BIA

Steve Bates has been the CEO of the UK Bioindustry Association since 2012. He currently chairs the International Council of Biotech Associations and has been a Board member of Europabio since 2015. Steve is the visible face of the vibrant UK life sciences industry to government and media. He sits on the UK’s Life Sciences Council and Life Sciences Industrial Strategy Implementation Board. Steve has championed with government effective industrial incentives like the Biomedical Cataylst which have crowded-in private sector investment into UK SMES. He has forged links for the sector across the USA, Europe and in China. In his time at the BIA Steve has developed new member groups focused on cell and gene therapy, genomics and engineered biology. A strong advocate of partnership working, Steve champions sector collaboration with research charities and academia. Proud to lead an organisation with a diverse Board with over 40% female representation, Steve is committed to next generation talent and developing the skills needed for the sector to flourish. Before the BIA, Steve worked for Genzyme and as an advisor to the UK Government of Tony Blair. He was made OBE for services to innovation in 2017.

Michael Warren

Strategic Policy Advisor

BIA

Michael joined the BIA in September to lead our policy and public affairs work on Brexit. He has extensive experience spanning a wide range of senior government and communications roles, most recently as a member of the executive team at Innovate UK, the UK’s innovation agency.

Priya Mande

Chief Operating Officer

PsiOxus Therapeutics

Priya Mande has over 25 years of experience in the pharmaceutical and biotech sector, 12 of which were at Glaxo Wellcome and GlaxoSmithKline where she was most recently senior Director of R&D Business Projects. She has held roles across research, development, finance and business strategy & operations. She was previously at PowderMed responsible for delivery of the vaccine immunotherapeutic portfolio. Priya was the Vaccine Research Project Leader for Influenza at Pfizer before becoming Chief Operating Officer of Hybrid BioSystems in 2009 which then formed PsiOxus Therapeutics in 2010. She joined the PsiOxus Board of Directors in 2016. Over 9 years she has overseen the growth of PsiOxus in the UK and USA and held responsibility for various parts of the business including project management, clinical development, regulatory, quality, legal, operations, HR, finance and company secretary. Priya studied Applied Biochemistry at Brunel University London, has a Diploma in Company Direction from the Institute of Directors and received her MBA with distinction from the London Business School.

 

 

Registration

This webinar is free to attend for members and non-members.

If you have any issues registering, or have not received a link to the webinar by Thursday morning, please contact BIAevents@bioindustry.org.

 

To view key information on the COVID-19 situation for BIA member companies and the life sciences sector please visit our dedicated microsite: www.biacovid19.org 

BIA Annual Supporters

Register